Media Summary: Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the James Blachly, MD, The Ohio State University, Columbus, OH, discusses measurable residual disease (
Methods To Evaluate Mrd In Aml - Detailed Analysis & Overview
Alexander Perl, MD, University of Pennsylvania, Philadelphia, PA, discusses the clinical meaning of measurable residual disease ... Sylvie Freeman, MBChB, MRCP, DPhil, FRCPath, University of Birmingham, Birmingham, UK, comments on the James Blachly, MD, The Ohio State University, Columbus, OH, discusses measurable residual disease ( Recorded on September 14th, 2023 as part of the Adult Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, briefly discusses the importance of investigating clonal ... In this video, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, explains the process of
Costa Bachas, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands, comments on the retrospective validation of ... Firas El Chaer, MD, University of Virginia, Charlottesville, VA, discusses various modalities to Thomas Cluzeau, MD, PhD, Central University Hospital of Nice, Nice, France, shares some insights into Christopher Hourigan, MD, DPhil, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, reflects on ... Watch the full course and our most up-to-date content here: Create a free account to track ... Experts expand on the practical and clinical use of minimal residual disease (
In this video, Gail Roboz, MD, Weill Cornell Medicine, New York City, NY, discusses the ongoing use of measurable residual ... Richard Stone, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the use of measurable residual disease ( Prof. Christopher S. Hourigan DM DPhil FACP FRCP Chief, Laboratory of Myeloid Malignancies National Heart, Lung and Blood ...
